Technologies

A continuum of technologies from the molecule to the patient at the forefront of innovation

For over 20 years, Oncodesign has invested in translational research technologies, which play a part in the initial phases of the Drug Discovery process.

Oncosnipe Set the direction at a very early stage for the research and development of therapeutic solutions for resistant and unresponsive patients.	Pharmimage Integrate our multi-modal pharmaco-imaging expertise with your preclinical and clinical projects	Nanocyclix The power and selectivity of Nanocyclix® molecules applied to the entire kinome..
Chi-mice Use our humanized models to reproduce the targeted pathology effectively: PDX, in vivo humanization of tissues from human stem cells (liver, immune system, skin, stroma, etc.).	T.O.T. Streamline the choice of therapeutic orientation for your projects by qualifying in vitro the potential of your molecules and your targets.	Predict Select the best drug candidates and their biomarkers by harnessing our pharmacological expertise

Their seamless integration with our Service, Partnership and Licensing offerings will help to power your innovation.

Oncodesign invests continually in the development of relevant and innovative new technologies. These developments can be conducted as part of a partnership, contact us today for more information.